Statistical flag only — not an accusation of fraud
⚠️ This provider averages 1.2K services per working day — physically unusual for an individual practitioner
Based on 2.9M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $29.6M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.
Averaging 1.2K services per working day raises questions about billing patterns.
Medicare payments to this provider grew 87% from 2014 to 2023.
This provider has been statistically flagged with a risk score of 66/100. Statistical flags are not accusations of fraud.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 63% in 2019
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $40.03 | $14.81 | 2.70x | $25.22 | $2.2M | 146.5K | 46 |
| 2015 | $36.88 | $13.48 | 2.74x | $23.40 | $3.0M | 219.2K | 51 |
| 2016 | $27.92 | $10.76 | 2.59x | $17.16 | $2.6M | 242.1K | 49 |
| 2017 | $22.97 | $8.28 | 2.77x | $14.69 | $2.2M | 266.6K | 52 |
| 2018 | $26.38 | $10.79 | 2.44x | $15.59 | $2.5M | 230.8K | 53 |
| 2019 | $27.09 | $10.20 | 2.66x | $16.89 | $4.1M | 399.2K | 60 |
| 2020 | $26.07 | $8.83 | 2.95x | $17.24 | $2.7M | 304.3K | 64 |
| 2021 | $25.60 | $8.18 | 3.13x | $17.42 | $3.2M | 385.6K | 62 |
| 2022 | $26.48 | $9.28 | 2.85x | $17.20 | $3.2M | 346.1K | 59 |
| 2023 | $39.12 | $10.97 | 3.57x | $28.15 | $4.1M | 370.4K | 61 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 102.7K | $4.2M | $41.20 | 2.26x |
| J9299 | Injection, nivolumab, 1 mg | 113.0K | $2.4M | $21.40 | 2.34x |
| J2505 | Injection, pegfilgrastim, 6 mg | 728 | $2.3M | $3.1K | 1.97x |
| J0897 | Injection, denosumab, 1 mg | 149.3K | $2.2M | $14.55 | 2.06x |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | 1.4K | $1.3M | $991.24 | 2.73x |
| J9310 | Injection, rituximab, 100 mg | 2.1K | $1.3M | $620.60 | 2.11x |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 34.7K | $1.1M | $32.60 | 3.89x |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 128.9K | $1.1M | $8.41 | 3.81x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 7.7K | $755.4K | $97.93 | 2.94x |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 22.3K | $730.4K | $32.74 | 4.08x |
| J9311 | Injection, rituximab 10 mg and hyaluronidase | 20.0K | $683.6K | $34.15 | 3.90x |
| J9035 | Injection, bevacizumab, 10 mg | 12.1K | $669.7K | $55.17 | 2.25x |
| J9355 | Injection, trastuzumab, 10 mg | 9.4K | $631.0K | $66.86 | 2.26x |
| J9041 | Injection, bortezomib, 0.1 mg | 20.5K | $571.0K | $27.79 | 3.27x |
| J9305 | Injection, pemetrexed, 10 mg | 11.7K | $566.5K | $48.24 | 2.32x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 7.4K | $560.5K | $75.64 | 1.87x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 9.9K | $555.6K | $56.26 | 1.75x |
| Q5108 | Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg | 3.3K | $518.3K | $158.21 | 4.24x |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 50.4K | $514.4K | $10.22 | 1.86x |
| J2796 | Injection, romiplostim, 10 micrograms | 6.8K | $444.7K | $64.92 | 1.97x |
This provider submits charges 2.88 times higher than what Medicare actually pays.
A markup ratio of 2.88x means for every $100 Medicare pays, this provider initially charges $288. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Hematology-Oncology providers in KS for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Pavan Reddy, M.D. | Wichita, KS | $52.9M | ⚠️ Flagged |
| Bassam Mattar, MD | Wichita, KS | $50.2M | ⚠️ Flagged |
| Dennis Moore, MD | Wichita, KS | $44.1M | ⚠️ Flagged |
| Shaker Dakhil, MD | Wichita, KS | $41.0M | ⚠️ Flagged |
| Jeremy Deutsch, MD | Wichita, KS | $39.7M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data